Single molecule actuators. The study of actuation processes in single molecules will lead to the development of improved advanced materials for Australian industry and, ultimately, to the more futuristic and exciting nanotechnologies. The research will improve our understanding of how polymer artificial muscles function, so that these materials can be further developed to meet the demand from industry. Applications include biomedical devices, robotic applicators and various machine parts. In ....Single molecule actuators. The study of actuation processes in single molecules will lead to the development of improved advanced materials for Australian industry and, ultimately, to the more futuristic and exciting nanotechnologies. The research will improve our understanding of how polymer artificial muscles function, so that these materials can be further developed to meet the demand from industry. Applications include biomedical devices, robotic applicators and various machine parts. In addition, the research will also contribute to one of the greatest promises of nanotechnology: the development of molecular machines. We will demonstrate the mechanical forces and movements possible from single molecules so that the design of useful nano-machines can begin.Read moreRead less
Development of a Novel Process for the Formation of Polymer Vesicles. The project would provide an increased understanding of polymer structures, polymer-drug interactions and dense gas processing of polymers. The novel process developed would be beneficial on a manufacturing level since it dramatically reduces processing time and minimises energy requirements. The research to be conducted is leading-edge technology that will attract business from international polymer, drug and biotechnology co ....Development of a Novel Process for the Formation of Polymer Vesicles. The project would provide an increased understanding of polymer structures, polymer-drug interactions and dense gas processing of polymers. The novel process developed would be beneficial on a manufacturing level since it dramatically reduces processing time and minimises energy requirements. The research to be conducted is leading-edge technology that will attract business from international polymer, drug and biotechnology companies. The development of world-class research provides Australia with recognition as a world leader in the field and strengthens and broadens the knowledge base of Australian scientists and engineers.Read moreRead less
Self-assembly of gelling biopolymer particles. Biopolymers provide a renewable source of structuring agents for a variety of potential uses in food, pharmaceutical and other applications that require bio-compatibility. Swollen biopolymer particles of sub-millimetre size are particularly useful as they combine macroscopic structure formation with an ability to flow and a desirable soft solid texture. Two limitations to the current utilisation of biopolymer particles are that they either cannot be ....Self-assembly of gelling biopolymer particles. Biopolymers provide a renewable source of structuring agents for a variety of potential uses in food, pharmaceutical and other applications that require bio-compatibility. Swollen biopolymer particles of sub-millimetre size are particularly useful as they combine macroscopic structure formation with an ability to flow and a desirable soft solid texture. Two limitations to the current utilisation of biopolymer particles are that they either cannot be predictably produced direct from a dried form, or if they are (e.g. cooked starch granules), there is a lack of scientific understanding that limits use of natural sources without subsequent chemical modification. This project will provide the science & technology to overcome these limitations.Read moreRead less
Biomaterial applications of synthetic elastin. The grant will develop a new collaboration between two established laboratories. The Weiss Lab (synthetic elastin; University of Sydney, Australia) will send elastin materials to the Langer Lab (interface of biotechnology and materials science; MIT, USA). Prof. Weiss will visit the Langer Lab and be trained in and participate collaboratively in the use of established MIT methodologies that will focus on applications in cardiac tissue engineering, co ....Biomaterial applications of synthetic elastin. The grant will develop a new collaboration between two established laboratories. The Weiss Lab (synthetic elastin; University of Sydney, Australia) will send elastin materials to the Langer Lab (interface of biotechnology and materials science; MIT, USA). Prof. Weiss will visit the Langer Lab and be trained in and participate collaboratively in the use of established MIT methodologies that will focus on applications in cardiac tissue engineering, controlled release of drugs and vocal fold repair. The MIT group will benefit from access to and the use of elastin materials that are developed in AustraliaRead moreRead less
Drug Delivery Devices : Hydrogels manufactured utilising Dense Gas Technologies. Many drugs are rapidly eliminated from the human body, and would benefit from being released over a long period of time. In this study, formulations to deliver drugs will be developed, using hydrogels: highly cross-linked, water saturated polymers. The polymers to be investigated are based on ingredients suitable for ingestion. Hydrogels are in common use as external therapeutic devices, such as contact lenses or wo ....Drug Delivery Devices : Hydrogels manufactured utilising Dense Gas Technologies. Many drugs are rapidly eliminated from the human body, and would benefit from being released over a long period of time. In this study, formulations to deliver drugs will be developed, using hydrogels: highly cross-linked, water saturated polymers. The polymers to be investigated are based on ingredients suitable for ingestion. Hydrogels are in common use as external therapeutic devices, such as contact lenses or wound dressings. However, hydrogels are not commonly in use as ingested drug delivery devices due to problems with the existing technologies, such as toxicity of ingredients. These problems will be addressed in this study.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0775684
Funder
Australian Research Council
Funding Amount
$230,000.00
Summary
The polymer pharmaceutical/drug characterization and processing facility. The Australian population is ageing, and this is leading to ever increasing burdens upon our health system. In addition new understanding of disease states has lead to a demand for improved materials for drug delivery and for tissue regeneration. This proposal will lead to novel biomaterials designed to meet these demands. Polymers are seen as essential elements for construction of such biomedical devices due to the myriad ....The polymer pharmaceutical/drug characterization and processing facility. The Australian population is ageing, and this is leading to ever increasing burdens upon our health system. In addition new understanding of disease states has lead to a demand for improved materials for drug delivery and for tissue regeneration. This proposal will lead to novel biomaterials designed to meet these demands. Polymers are seen as essential elements for construction of such biomedical devices due to the myriad forms in which they can be made, and the large number of different materials to choose from. This proposal will lead to the formation of the PolyPharma network which will produce polymeric biomaterials to benefit our health industries.Read moreRead less
Carbon Dioxide: Solvent, Carrier and Reagent, for novel polymer networks with controlled nano-architectures. The proposed environmentally friendly technology has broad applications for improving properties of various polymeric matrices used for biomedical applications. The process developed would value-add for manufacturing biomedical polymeric devices in Australia with licensing of existing fabrication methods as a best option. Moreover, the leading-edge polymer technology developed would mini ....Carbon Dioxide: Solvent, Carrier and Reagent, for novel polymer networks with controlled nano-architectures. The proposed environmentally friendly technology has broad applications for improving properties of various polymeric matrices used for biomedical applications. The process developed would value-add for manufacturing biomedical polymeric devices in Australia with licensing of existing fabrication methods as a best option. Moreover, the leading-edge polymer technology developed would minimise the organic solvent consumption and will attract business from international polymer and biotechnology companies for production of implant and drug delivery devices. The development of world-class research provides Australia with recognition as a world leader in the field and broadens the knowledge based of Australian scientist and engineers.Read moreRead less